Certara

@Certara

Certara is the global leader in advancing modern, efficient drug development.

Princeton, NJ (Headquarters)
Vrijeme pridruživanja: studeni 2011.

Tweetovi

Blokirali ste korisnika/cu @Certara

Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @Certara

  1. Prikvačeni tweet
    23. sij

    - More than 90% of novel new drug approvals by the US Food and Drug Administration () in 2019 were supported by Certara or services. To read the full press release, visit

    Poništi
  2. prije 9 sati

    On Thursday, February 13th be sure to join our with a live Q&A session to learn how you should prepare to assess price and value through emerging assessments and novel frameworks. Register here:

    Poništi
  3. prije 12 sati

    Our 2019 best of the blog book is your guide to the industry’s latest trends in modeling and simulation (M&S), regulatory science, and real-world value assessment. Download it here:

    Poništi
  4. 5. velj

    Certara is dedicated to supporting safer and more effective cancer drugs.

    Poništi
  5. 4. velj

    Certara is dedicated to supporting safer and more effective cancer drugs.

    Poništi
  6. proslijedio/la je Tweet
    4. velj

    Today, we celebrate all the innovative breakthroughs that have increased the quality of life for cancer patients around the world—making cancer more beatable than ever!

    Poništi
  7. 3. velj

    - Last week we provided a webinar that gave an overview of the major additions to the Simulator’s ADAM and M-ADAM models. Watch it here:

    Poništi
  8. 2. velj

    Looking for a new opportunity? Click here to explore some of our latest hot :

    Poništi
  9. 1. velj

    Join the Certara team! We have exciting opportunities to work with hundreds of biopharmaceutical companies, leading academic institutions, and key regulatory agencies worldwide! Find a position that fits you here:

    Poništi
  10. 1. velj

    Certara is hiring an Associate Scientist within our Strategic Consulting division! This position will be based in - Learn more:

    Poništi
  11. 31. sij

    - Demonstrating bioequivalence (BE) with Certara’s Simcyp MechDermA Model. Read here:

    Poništi
  12. 30. sij

    Join our new 3-day classroom course that teaches students to go beyond NCA! Learn to model and simulate individual and population data. Session coming up 24-26 March 2020 in . To learn more and register, visit

    Poništi
  13. proslijedio/la je Tweet
    28. sij

    As competition for increasingly constrained healthcare budgets continues to rise, learn about some of the most common tools and field teams are using to secure market access:

    Poništi
  14. 28. sij

    Don't miss out on our first webinar of 2020! Tomorrow we will present, "Updates to the Simcyp Simulator’s Oral Absorption ADAM and M-ADAM Models." Register now:

    Poništi
  15. 27. sij

    [2/13 Webinar] We'll discuss how pricing has evolved from the 1990s to today for the rare disease drug market and much more! Register here:

    Poništi
  16. 24. sij

    Certara University is offering LIVE online classroom course focused on learning Noncompartmental analysis (NCA) using Phoenix WinNonlin. To learn more and register, visit

    Poništi
  17. 23. sij

    Free! A compilation of Certara’s biggest challenges and accomplishments in model-informed drug development, health economics/outcomes research and real world evidence, and regulatory science, strategy, and services. To download the blog book, visit

    Poništi
  18. proslijedio/la je Tweet

    Precision medicine - a reality or just hype? In this opinion article, the authors from , , and , provide a overview of precision medicine using model-informed precision dosing as an example 👉

    Poništi
  19. proslijedio/la je Tweet
    22. sij

    Global Head of Transparency & Disclosure, , delving in to prospective & retrospective analyses of clinical disclosure & data sharing requirements.

    Poništi
  20. 22. sij

    [1/29 Webinar] Learn about recent additions to the ADAM/M-ADAM mechanistic models in version 19 of the Simcyp Population-based PBPK Simulator. Register here:

    Poništi

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.

    Možda bi vam se svidjelo i ovo:

    ·